A multicenter, blinded, placebo-controlled study to investigate the effects of everolimus and/or BEZ235 on the immune response to vaccination in the elderly.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 01 Aug 2016

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Dactolisib (Primary) ; Everolimus; Influenza virus vaccine (Afluria); Influenza virus vaccine (Afluria)
Indications Influenza virus infections
Focus Adverse reactions; Pharmacodynamics
Sponsors Novartis Institutes for BioMedical Research

08 Jun 2016 Status changed from active, no longer recruiting to completed.
21 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by Australian New Zealand Clinical Trials Registry.
05 Feb 2014 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com